Follow
adina popa
adina popa
Verified email at umfcluj.ro
Title
Cited by
Cited by
Year
An overview of healthcare associated infections and their detection methods caused by pathogen bacteria in Romania and Europe
S Szabó, B Feier, D Capatina, M Tertis, C Cristea, A Popa
Journal of clinical medicine 11 (11), 3204, 2022
402022
Pharmacokinetic interaction between ivabradine and carbamazepine in healthy volunteers
L Vlase, M Neag, A Popa, D Muntean, I Bâldea, SE Leucuta
Journal of Clinical Pharmacy and Therapeutics 36 (2), 225-229, 2011
402011
Potentially inappropriate medications in elderly ambulatory and institutionalized patients: an observational study
DP Primejdie, MT Bojita, A Popa
BMC Pharmacology and Toxicology 17, 1-10, 2016
372016
A pharmacokinetic drug interaction study between nebivolol and paroxetine in healthy volunteers
C Briciu, M Neag, D Muntean, L Vlase, C Bocsan, A Buzoianu, ...
Journal of clinical pharmacy and therapeutics 39 (5), 535-540, 2014
362014
Pharmacokinetic interaction between zolpidem and carbamazepine in healthy volunteers
L Vlase, A Popa, M Neag, D Muntean, I Bâldea, SE Leucuta
The Journal of Clinical Pharmacology 51 (8), 1233-1236, 2011
302011
Pharmacokinetic interaction between zolpidem and ciprofloxacin in healthy volunteers
L Vlase, A Popa, M Neag, D Muntean, SE Leucuța
European journal of drug metabolism and pharmacokinetics 35, 83-87, 2011
302011
Pharmacokinetic interaction between ivabradine and phenytoin in healthy subjects
L Vlase, A Popa, M Neag, D Muntean, SE Leucuta
Clinical drug investigation 32, 533-538, 2012
272012
Evaluation of a potential metabolism-mediated drug-drug interaction between atomoxetine and bupropion in healthy volunteers
I Todor, A Popa, M Neag, D Muntean, C Bocsan, A Buzoianu, L Vlase, ...
Journal of Pharmacy & Pharmaceutical Sciences 19 (2), 198-207, 2016
242016
Phenotypic differences in nebivolol metabolism and bioavailability in healthy volunteers
C Briciu, M Neag, D Muntean, C Bocsan, A Buzoianu, O Antonescu, ...
Clujul Medical 88 (2), 208, 2015
242015
Assessment of a potential pharmacokinetic interaction between nebivolol and bupropion in healthy volunteers
AM Gheldiu, A Popa, M Neag, D Muntean, C Bocsan, A Buzoianu, L Vlase, ...
Pharmacology 98 (3-4), 190-198, 2016
222016
Evaluation of restricted antibiotic use in a hospital in Romania
P Tarcea Bizo, D Dumitras, A Popa
International journal of clinical pharmacy 37, 452-456, 2015
222015
Validation of HPLC-UV method for analysis of omeprazole in presence of its metabolites in human plasma
C Iuga, M Moldovan, A Popa, SE Leucuta
FARMACIA-BUCURESTI- 56 (3), 254, 2008
182008
E-Financial reporting within the Romanian public sector governance
AT Tudor, R Blidisel, A Popa
Conference on e-Government at Westminster Business School University of …, 2009
162009
Evaluation of the potential pharmacokinetic interaction between atomoxetine and fluvoxamine in healthy volunteers
I Todor, A Popa, M Neag, D Muntean, C Bocsan, A Buzoianu, L Vlase, ...
Pharmacology 99 (1-2), 84-88, 2017
132017
Effect of fluvoxamine on the pharmokinetics of zolpidem: A two‐treatment period study in healthy volunteers
L Vlase, A Popa, M Neag, D Muntean, M Achim, SE Leucuța
Clinical and Experimental Pharmacology and Physiology 39 (1), 9-12, 2012
132012
Effect of fluoxetine on the pharmacokinetics of lansoprazole: a two-treatment period study in healthy male subjects
L Vlase, A Popa, M Neag, D Muntean, SE Leucuta
Clinical Drug Investigation 31, 727-733, 2011
122011
Pharmacokinetics and comparative bioavailability of two fenofibrate capsule formulations in healthy volunteers
L Vlase, A Popa, D Muntean, SE Leucuta
Arzneimittelforschung 60 (09), 560-563, 2010
122010
Pharmaceutical care and pharmacy education in Romania
A Popa, O Crisan, R Sandulescu, M Bojita
Pharmacy Education 2 (1), 11-14, 2002
122002
Pharmacokinetic interaction between fluoxetine and omeprazole in healthy male volunteers: a prospective pilot study
L Vlase, M Neag, A Popa, D Muntean, SE Leucuta
Current therapeutic research 71 (6), 360-368, 2010
112010
Linezolid administration to critically ill patients: intermittent or continuous infusion? A systematic literature search and review
LA Hui, C Bodolea, L Vlase, EI Hiriscau, A Popa
Antibiotics 11 (4), 436, 2022
102022
The system can't perform the operation now. Try again later.
Articles 1–20